Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Stydnicki

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cancer|March 15, 1989
Clinical experience with leucovorin and 5-fluorouracilL R Laufman, W D Brenckman, K A Stydnicki, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Clinical experience with CF-FUraL R Laufman, W D Brenckman, K A Stydnicki, et al.
Cancer|April 1, 1995
Decline of posttreatment tumor marker levels after therapy of nonsmall cell lung cancer. A useful outcome predictorC H Spiridonidis, L R Laufman, K A Stydnicki, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cancer|March 15, 1989
Clinical experience with leucovorin and 5-fluorouracilL R Laufman, W D Brenckman, K A Stydnicki, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Clinical experience with CF-FUraL R Laufman, W D Brenckman, K A Stydnicki, et al.
Cancer|April 1, 1995
Decline of posttreatment tumor marker levels after therapy of nonsmall cell lung cancer. A useful outcome predictorC H Spiridonidis, L R Laufman, K A Stydnicki, et al.
Pageof 1